[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349524-105":59,"doc-detail-349524-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","persistent-cardiovascular-burden-and-independent-association-among-cancer-survivors-in-the-united-states-2016-to-2024-original-research","Persistent Cardiovascular Burden and Independent Association Among Cancer Survivors in the United States, 2016 to 2024 - Original Research","","Cardiovascular disease remains a leading non-cancer contributor to morbidity and mortality among cancer survivors, yet national trends and independent links with prevalent cardiovascular disease have not been fully characterized. Using 2016–2024 Behavioral Risk Factor Surveillance System data, two nationally representative cohorts were analyzed for trends and associations. Cancer survivorship showed persistently elevated cardiovascular disease prevalence without temporal decline, with an adjusted independent absolute difference of 3.0% and increased odds of prevalent disease.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/persistent-cardiovascular-burden-and-independent-association-among-cancer-survivors-in-the-united-states-2016-to-2024-original-research/349524/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/persistent-cardiovascular-burden-and-independent-association-among-cancer-survivors-in-the-united-states-2016-to-2024-original-research/349524.png","ImageObject",300,407,{"name":92,"@type":93},"PakDamar76","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How did cardiovascular disease prevalence among cancer survivors change from 2016 to 2024?","Question",{"text":112,"@type":113},"Age-standardized cardiovascular disease prevalence among cancer survivors stayed persistently about double that of the general population, with no significant temporal decline.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What methods were used to evaluate the association between cancer survivorship and cardiovascular disease?",{"text":117,"@type":113},"The study used Joinpoint regression for trend assessment and inverse probability of treatment weighting to estimate the independent association between cancer survivorship and cardiovascular disease.",{"name":119,"@type":110,"acceptedAnswer":120},"Which groups showed stronger cardiovascular associations after adjustment?",{"text":121,"@type":113},"Associations were stronger among survivors younger than 65 years and among those without traditional metabolic comorbidities.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349524,1790889133,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893057,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Journal of the American Heart Association  \nORIGINAL RESEARCH  \n\n| Persistent Cardiovascular Burden and Independent Association Among Cancer Survivors in the United States, 2016 to 2024\u003Cbr>Xinhui Liu, PhD; Shuo Wu  , MS; Jiqing Li  , PhD; Jianhua Gu  , PhD\u003Cbr>BACKGROUND: Cardiovascular disease (CVD) is a leading cause of morbidity among cancer survivors. However, contemporary trends and independent association between cancer survivorship and prevalent CVD remain incompletely characterized.\u003Cbr>METHODS: Using 2016 to 2024 Behavioral Risk Factor Surveillance System data, we analyzed 2 nationally representative cohorts of US adults. A trend cohort (n=3 642 415) assessed age-standardized CVD prevalence via Joinpoint regression. An association cohort (n=829 958) isolated the association between cancer survivorship and CVD using inverse probability of treatment weighting.\u003Cbr>RESULTS: From 2016 to 2024, age-standardized CVD prevalence among cancer survivors was persistently double that of the general population (12 .9%–15 .0% versus 6.8%), with no significant temporal decline. In unadjusted analysis to determine the absolute burden, survivors had 11.7% higher CVD prevalence than controls. After inverse probability of treatment weighting adjustment, a significant absolute prevalence difference of 3.0% persisted. Consequently, cancer survivorship was independently associated with prevalent CVD (odds ratio [OR], 1.22 [95% CI, 1.18–1.27=; E-value=1.76) . Associations were stronger among survivors aged \u003C65 years (OR, 1.82 [95% CI, 1.58–2.08]) and those without traditional metabolic comorbidities (OR, 1.71 [95% CI, 1.50–1.95]) . Site-specific analyses revealed robust independent associations for prostate and colorectal cancers, whereas associations observed for breast and lung cancers were largely attenuated after adjustment for age and smoking-related factors, respectively.\u003Cbr>CONCLUSIONS: The CVD burden among US cancer survivors remains persistently high. Independent of traditional factors, cancer survivorship is associated with a distinct cardiovascular burden, particularly among younger individuals and those with a low-risk metabolic profile. These findings support extending cardiovascular surveillance to conventionally low-risk subgroups.\u003Cbr>Key Words: Behavioral Risk Factor Surveillance System ■ cancer survivorship ■ cardiovascular risk factors ■ population-based study\u003Cbr>■ temporal trends |  |\n| --- | --- |\n| Cancer is the second leading cause of death\u003Cbr>both in the United States and globally.1 Although\u003Cbr>the incidence of new cases continues to rise, imposing substantial public health and socioeconomic burdens,1 advances in early detection and therapeutic strategies have led to a sustained decline in cancer mortality. Consequently, the population of cancer survivors is expanding rapidly. According to the National | Cancer Institute, there are currently approximately 18.1 million cancer survivors in the United States, a number projected to reach 26 million by 2040.2 As survival improves, non-cancer-related conditions have become increasingly critical determinants of long-term prognosis.\u003Cbr>Cardiovascular disease (CVD) has emerged as the leading noncancer cause of morbidity and mortality in |\n\nCorrespondence to: Jianhua Gu, PhD, Qilu Hospital of Shandong University, 107 Wenhua West Road, Lixia District, Jinan, Shandong Province, China.  \nEmail: [jianhuagu@yeah.net](jianhuagu@yeah.net)  \nThis article was sent to Olufunmilayo H. Obisesan, MD, MPH, Associate Editor, for review by expert referees, editorial decision, and final disposition. Supplemental Material is available at [https://www.ahajournals.org/doi/suppl/10.1161/JAHA.126.049666](https://www.ahajournals.org/doi/suppl/10.1161/JAHA.126.049666)  \n[For Sources of Funding and Disclosures](For Sources of Funding and Disclosures) , see page 13.  \n© 2026 The Author(s) . Published on behalf of the American Heart Association, Inc. , by Wiley. This is an open access article under the term","cbCaigkycQHLkCWH","https://ap.wps.com/l/cbCaigkycQHLkCWH","pdf",419292,15,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Clinical Perspective","[{\"question\":\"How did cardiovascular disease prevalence among cancer survivors change from 2016 to 2024?\",\"answer\":\"Age-standardized cardiovascular disease prevalence among cancer survivors stayed persistently about double that of the general population, with no significant temporal decline.\"},{\"question\":\"What methods were used to evaluate the association between cancer survivorship and cardiovascular disease?\",\"answer\":\"The study used Joinpoint regression for trend assessment and inverse probability of treatment weighting to estimate the independent association between cancer survivorship and cardiovascular disease.\"},{\"question\":\"Which groups showed stronger cardiovascular associations after adjustment?\",\"answer\":\"Associations were stronger among survivors younger than 65 years and among those without traditional metabolic comorbidities.\"}]","Persistent Cardiovascular Burden and Independent Association Among Cancer Survivors in the United States, 2016 to 2024 - Original Research | PDF",1790084169,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/884c0071e8b7040f36b3bdd3f2ca32c8.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16873bb18695413c77209206c2489e11.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/069067b7aaea256aea0f3acad2ebeecc.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b19911553a339223051896e8278a1e9a.webp",980,1287]